Display options
Cite
Skovlund PC, Vind Thaysen H, Schmidt H, et al. Effect of patient-reported outcomes as a dialogue-based tool in cancer consultations on patient self-management and health-related quality of life: a clinical, controlled trial. Acta Oncol. 2021;60(12):1668-1677doi: 10.1080/0284186X.2021.1962972.
Skovlund, P. C., Vind Thaysen, H., Schmidt, H., Alsner, J., Hjollund, N. H., Lomborg, K., & Nielsen, B. K. (2021). Effect of patient-reported outcomes as a dialogue-based tool in cancer consultations on patient self-management and health-related quality of life: a clinical, controlled trial. Acta oncologica (Stockholm, Sweden), 60(12), 1668-1677. https://doi.org/10.1080/0284186X.2021.1962972
Skovlund, Pernille Christiansen, et al. "Effect of patient-reported outcomes as a dialogue-based tool in cancer consultations on patient self-management and health-related quality of life: a clinical, controlled trial." Acta oncologica (Stockholm, Sweden) vol. 60,12 (2021): 1668-1677. doi: https://doi.org/10.1080/0284186X.2021.1962972
Skovlund PC, Vind Thaysen H, Schmidt H, Alsner J, Hjollund NH, Lomborg K, Nielsen BK. Effect of patient-reported outcomes as a dialogue-based tool in cancer consultations on patient self-management and health-related quality of life: a clinical, controlled trial. Acta Oncol. 2021 Dec;60(12):1668-1677. doi: 10.1080/0284186X.2021.1962972. Epub 2021 Aug 17. PMID: 34403293.
Copy Download .nbib Format: NLM
Share it on

Acta Oncol. 2021 Dec;60(12):1668-1677. doi: 10.1080/0284186X.2021.1962972. Epub 2021 Aug 17.

Effect of patient-reported outcomes as a dialogue-based tool in cancer consultations on patient self-management and health-related quality of life: a clinical, controlled trial.

Acta oncologica (Stockholm, Sweden)

Pernille Christiansen Skovlund, Henriette Vind Thaysen, Henrik Schmidt, Jan Alsner, Niels Henrik Hjollund, Kirsten Lomborg, Berit Kjærside Nielsen

Affiliations

  1. Experimental Clinical Oncology, Department of Oncology, Aarhus University Hospital, Aarhus N, Denmark.
  2. Department of Oncology, Aarhus University Hospital, Aarhus N, Denmark.
  3. The Research Centre for Patient Involvement, Aarhus University & the Central Denmark Region, Aarhus N, Denmark.
  4. Department of Surgery, Aarhus University Hospital, Aarhus N, Denmark.
  5. AmbuFlex - Center for Patient-reported Outcomes, Hospital Unit West Jutland, Herning, Denmark.
  6. Faculty of Health, Department of Clinical Medicine, Aarhus University, Aarhus N, Denmark.
  7. Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus N, Denmark.
  8. Steno Diabetes Center Copenhagen, Gentofte, Denmark.
  9. DEFACTUM, Social & Health Services and Labour Market, Central Denmark Region, Aarhus N, Denmark.

PMID: 34403293 DOI: 10.1080/0284186X.2021.1962972

Abstract

BACKGROUND: With increased survival among patients with metastatic melanoma and limited time with health care providers, patients are expected to assume a more active role in managing their treatment and care. Activated patients have the knowledge, skills, and confidence to make effective solutions to self-manage health. The use of patient-reported outcomes (PRO) could have the potential to enhance patient activation. However, PRO-based interventions that facilitate an activation in patients with metastatic melanoma are lacking and warranted.

MATERIAL AND METHODS: In this prospective non-randomized controlled, clinical trial, patients with metastatic melanoma were assigned to either the intervention (systematic feedback and discussion of PRO during consultation) given at one hospital or the control group (treatment as usual) if they received treatment from two other hospitals in Denmark. The primary outcome was the patient activation measure (PAM), which reflects self-management. Secondary outcomes were health-related quality of life (HRQoL), self-efficacy, and Patient-Physician interaction. Outcomes were measured at baseline, and after 3, 6, and 12 months. The analysis of the effect from baseline to 12 months employed mixed-effects modeling.

RESULTS: Between 2017 and 2019, patients were allocated to either the intervention group (

CONCLUSION: The intervention did not improve knowledge, skills, and confidence for self-management for patients with metastatic melanoma. Neither did it improve coping self-efficacy nor perceived efficacy in Patient-Physician interaction. However, the results suggest that the intervention can have a significant impact on HRQoL and in particular social and emotional well-being among the females.

Keywords: HRQoL; Patient-reported outcomes; communication; metastatic melanoma; patient activation measure

Publication Types